Selected genodermatoses – Status quo and future prospects

zu Verbundenen Objekten

Abstract: Genodermatoses are monogenetic disorders, which may manifest with symptoms either exclusively on the skin or also involve other organs in the context of an associated syndrome. Over the past 30 years, numerous hereditary hair, tumor, blistering, and keratinization diseases have been characterized both clinically and genetically. This has resulted in the continuous development of disease-specific classifications as well as diagnostic algorithms and examination techniques, and has also led to new pathogenesis-based therapeutic approaches. While the deciphering of the underlying genetic defects of these diseases is already well advanced, there is still much room for the development of new translationally motivated treatment strategies

Standort
Deutsche Nationalbibliothek Frankfurt am Main
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
Journal der Deutschen Dermatologischen Gesellschaft. - 21, 4 (2023) , 337-341, ISSN: 1610-0387

Ereignis
Veröffentlichung
(wo)
Freiburg
(wer)
Universität
(wann)
2023
Urheber

DOI
10.1111/ddg.15054
URN
urn:nbn:de:bsz:25-freidok-2365808
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
25.03.2025, 13:53 MEZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

Entstanden

  • 2023

Ähnliche Objekte (12)

Treatment of epidermolysis bullosa and future directions: a review

Treatment of epidermolysis bullosa and future directions: a review

Strategy for the optimization of read-through therapy for junctional epidermolysis bullosa with COL17A1 nonsense mutation

Strategy for the optimization of read-through therapy for junctional epidermolysis bullosa with COL17A1 nonsense mutation

Dupilumab bessert kongenitale Ichthyose : = Dupilumab improves congenital ichthyosis

Dupilumab bessert kongenitale Ichthyose : = Dupilumab improves congenital ichthyosis

Dupilumab improves congenital ichthyosis

Dupilumab improves congenital ichthyosis

Advances in understanding the molecular basis of skin fragility

Advances in understanding the molecular basis of skin fragility

Ausgewählte Genodermatosen – Stand der Dinge und Zukunftsaussichten

Ausgewählte Genodermatosen – Stand der Dinge und Zukunftsaussichten

Secukinumab for the treatment of SAM syndrome associated with desmoglein‐1 deficiency

Secukinumab for the treatment of SAM syndrome associated with desmoglein‐1 deficiency

Update on genetic conditions affecting the skin and the kidneys

Update on genetic conditions affecting the skin and the kidneys

Molecular therapeutics in development for Epidermolysis bullosa: update 2020

Molecular therapeutics in development for Epidermolysis bullosa: update 2020

Kindler syndrome in a patient with colitis and primary sclerosing cholangitis : : coincidence or association?

Kindler syndrome in a patient with colitis and primary sclerosing cholangitis : : coincidence or association?

Dupilumab improves itch and blistering in different subtypes of epidermolysis bullosa

Dupilumab improves itch and blistering in different subtypes of epidermolysis bullosa

Dupilumab verbessert Juckreiz und Blasenbildung bei verschiedenen Subtypen der Epidermolysis bullosa : = Dupilumab improves itch and blistering in different subtypes of epidermolysis bullosa

Dupilumab verbessert Juckreiz und Blasenbildung bei verschiedenen Subtypen der Epidermolysis bullosa : = Dupilumab improves itch and blistering in different subtypes of epidermolysis bullosa

Verbundene Objekte